Altria Says With Administrative Stay From FDA Now In Place, Continue To Offer Products To Adult Smokers While We Pursue Agency’s Internal Review Process

-Reuters

-Reuters

Total
0
Shares
Related Posts
Read More

Akari Therapeutics Presents Poster On Progress In Pre-Clinical Development Of Long-Acting PAS-Nomacopan As A Potential Treatment For Geographic Atrophy At The 4th Annual Dry AMD Therapeutic Development Conference

Akari Therapeutics, Plc (NASDAQ:AKTX), a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, today announced the presentation of progress in the development of

AKTX

Read More

S&P 500 Settles Lower, Market Volatility Rises

The S&P 500 closed lower on Wednesday, as weak economic data raised recession concerns. Private businesses in the U.S. added 145,000 jobs in March versus a revised 261,000 in February and compared to expectations of 200,000, the ADP said. The Institute for Supply Management said that its non-manufacturing PMI dropped to 51.2 in March from 55.1 in February.

AAPL